Drugs / Zishen Yutai Pill
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07641088 | Jul 2026 → Dec 2029 expected | infertility disorder | Peking University Third Hospital | Not yet recruiting | No outcome recorded |
| — | NCT03703700 | Mar 2019 → Sep 2024 | female infertility | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Zishen Yutai Pill | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07641088 ↗ |
| Known as | ZYP | “In a large randomized trial, Zishen Yutai Pill (ZYP) improved LBR in the general population, and a subsequent post hoc analysis suggested efficacy in AMA women, though it was...” PMID 41444477 ↗ Dec 20251“The goal of this clinical trial is to evaluate the efficacy of Zishen Yutai Pill (ZYP) on pregnancy outcomes following embryo transfer and its safety in patients with recurrent...” NCT07641088 ↗ |
| Route | Oral | “Women aged 35-42 years with BMI < 28 kg/m2 at 12 tertiary-level hospitals in China were randomly assigned to receive ZYP or placebo orally (5 g once, three times daily) from...” PMID 41444477 ↗ Dec 2025 |